91 related articles for article (PubMed ID: 3814214)
41. A comparison of the haemodynamic effects of nifedipine, nisoldipine and nitrendipine in man.
Debbas NM; Jackson SH; Turner P
Eur J Clin Pharmacol; 1986; 30(4):393-7. PubMed ID: 2943594
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine.
van Harten J; van Brummelen P; Lodewijks MT; Danhof M; Breimer DD
Clin Pharmacol Ther; 1988 Mar; 43(3):332-41. PubMed ID: 3345623
[TBL] [Abstract][Full Text] [Related]
43. Absolute left ventricular volume changes after sublingual nitroglycerine and nifedipine intervention.
Otto AC; Herbst CP; van Aswegen A; Lötter MG; Minnaar PC; Marx JD; Kleynhans PH
S Afr Med J; 1987 May; 71(10):633-6. PubMed ID: 3107141
[TBL] [Abstract][Full Text] [Related]
44. Influence of renal function on the pharmacokinetics and cardiovascular effects of nisoldipine after single and multiple dosing.
van Harten J; Burggraaf J; van Brummelen P; Breimer DD
Clin Pharmacokinet; 1989 Jan; 16(1):55-64. PubMed ID: 2706880
[TBL] [Abstract][Full Text] [Related]
45. Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration.
van Harten J; van Brummelen P; Wilson JH; Lodewijks MT; Breimer DD
Eur J Clin Pharmacol; 1988; 34(4):387-94. PubMed ID: 3402524
[TBL] [Abstract][Full Text] [Related]
46. Effect of long-term oral nifedipine therapy on left ventricular regional wall function at rest and during supine bicycle exercise.
Bos RJ; Serruys PW; Brower RW; ten Katen HJ; Vanhaleweyk G; Hugenholtz PG
Eur Heart J; 1985 Apr; 6(4):349-57. PubMed ID: 3875486
[TBL] [Abstract][Full Text] [Related]
47. Ischemia-induced changes in sarcolemmal (Na+, K+)-ATPase, K+-pNPPase, sialic acid, and phospholipid in the dog and effects of the nisoldipine and chlorpromazine treatment.
Takahashi K; Kako KJ
Biochem Med; 1984 Jun; 31(3):271-86. PubMed ID: 6089773
[TBL] [Abstract][Full Text] [Related]
48. The effect of a calcium channel antagonist, Nisoldipine, on the ischemia-induced change of canine sarcolemmal membrane.
Takahashi K; Kako KJ
Basic Res Cardiol; 1983; 78(3):326-37. PubMed ID: 6311155
[TBL] [Abstract][Full Text] [Related]
49. Increased left ventricular emptying at maximal exercise after reduction in afterload.
Andersen K; Vik-Mo H
Circulation; 1984 Mar; 69(3):492-6. PubMed ID: 6692510
[TBL] [Abstract][Full Text] [Related]
50. [Evaluation of peak filling rate for the early identification of daunorubicin cardiotoxicity].
Trappolini M; Matteoli S; Galli V; Grego V
G Ital Cardiol; 1988 Jan; 18(1):55-60. PubMed ID: 3384249
[TBL] [Abstract][Full Text] [Related]
51. Effects of calcium antagonists in patients with coronary disease and heart failure: left ventricular function following nisoldipine measured by radionuclide ventriculography.
Eichstaedt H
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S50-4. PubMed ID: 1282615
[TBL] [Abstract][Full Text] [Related]
52. Response of left and right ventricle rate indices to exercise in normal volunteers.
Hassan IM; Mohammed MM; Badrudoza M; Taha B; Kouris K; Abdel-Dayem HM
Nucl Med Commun; 1988 Nov; 9(11):871-8. PubMed ID: 3251175
[TBL] [Abstract][Full Text] [Related]
53. Acute effects of intravenous nisoldipine on left ventricular function after acute myocardial infarction.
van der Wall EE; Cats VM; Chin JC; Pauwels EJ; Bruschke AV
Cardiovasc Drugs Ther; 1994 May; 8 Suppl 2():345-51. PubMed ID: 7947377
[TBL] [Abstract][Full Text] [Related]
54. Clinical application of exercise stress echocardiography: supine bicycle or treadmill?
Dagianti A; Penco M; Bandiera A; Sgorbini L; Fedele F
Am J Cardiol; 1998 Jun; 81(12A):62G-67G. PubMed ID: 9662230
[TBL] [Abstract][Full Text] [Related]
55. Beneficial effects of sublingual nifedipine in patients with ischemic heart disease and depressed left ventricular function.
Losardo AA; Klein NA; Beer N; Strom JA; Wexler JP; Sonnenblick EH; Frishman WH
Angiology; 1982 Dec; 33(12):811-7. PubMed ID: 7181173
[No Abstract] [Full Text] [Related]
56. The effect of the new calcium antagonist nisoldipine (BAY k-5552) on myocardial infarct size limitation in conscious dogs.
Crottogini AJ; Depaoli JR; Barra JG; Fischer EC; Rodríguez Chatruc M; Pichel RH; de la Fuente L
Am Heart J; 1985 Oct; 110(4):753-60. PubMed ID: 4050646
[TBL] [Abstract][Full Text] [Related]
57. Cardioprotective actions of nisoldipine in postreperfusion myocardial ischemia.
Mentley RK; Brezinski ME; Tse E; Lefer AM
Am Heart J; 1988 May; 115(5):948-54. PubMed ID: 3364351
[TBL] [Abstract][Full Text] [Related]
58. Plasma endothelin-1 concentrations in patients with coronary artery disease during stress test before and after nisoldipine administration.
Letizia C; Barillà F; Cerci S; De Ciocchis A; Coassin S; Mastroianni MA; D'Ambrosio C; Campa PP; Scavo D
Acta Cardiol; 1996; 51(2):165-72. PubMed ID: 8742913
[TBL] [Abstract][Full Text] [Related]
59. The actions of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro.
Godfraind T; Eglème C; Finet M; Jaumin P
Pharmacol Toxicol; 1987 Aug; 61(2):79-84. PubMed ID: 3671330
[TBL] [Abstract][Full Text] [Related]
60. The efficacy of nifedipine and acebutolol in coronary artery disease assessed by radionuclide ventriculography.
Bauer R; Busch U; Lutilsky L; van de Flierdt E; Langhammer HR; Pabst HW
Cardiovasc Drugs Ther; 1989 Jun; 3 Suppl 1():287-93. PubMed ID: 2487800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
